Welcome to LookChem.com Sign In|Join Free
  • or
Butanoic acid, 4-(4-chlorophenoxy)-3-oxo-, ethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

97900-77-1

Post Buying Request

97900-77-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

97900-77-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 97900-77-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,9,0 and 0 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 97900-77:
(7*9)+(6*7)+(5*9)+(4*0)+(3*0)+(2*7)+(1*7)=171
171 % 10 = 1
So 97900-77-1 is a valid CAS Registry Number.

97900-77-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 2-(4-chlorophenoxy)-acetoacetate

1.2 Other means of identification

Product number -
Other names TC-II-148

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:97900-77-1 SDS

97900-77-1Relevant academic research and scientific papers

ADME-guided design and synthesis of aryloxanyl pyrazolone derivatives to block mutant superoxide dismutase 1 (SOD1) cytotoxicity and protein aggregation: Potential application for the treatment of amyotrophic lateral sclerosis

Chen, Tian,Benmohamed, Radhia,Kim, Jinho,Smith, Karen,Amante, Daniel,Morimoto, Richard I.,Kirsch, Donald R.,Ferrante, Robert J.,Silverman, Richard B.

experimental part, p. 515 - 527 (2012/03/26)

Amyotrophic lateral sclerosis (ALS) is an orphan neurodegenerative disease currently without a cure. The arylsulfanyl pyrazolone (ASP) scaffold was one of the active scaffolds identified in a cell-based high throughput screening assay targeting mutant Cu/

PYRAZOLE DERIVATIVES, PREPARATION METHOD THEREOF, AND COMPOSITION FOR PREVENTION AND TREATMENT OF OSTEOPOROSIS CONTAINING SAME

-

Page/Page column 9, (2012/09/22)

The present invention provides pyrazole derivative compounds and pharmaceutically acceptable salts thereof. The compounds of the present invention have an excellent effect of preventing and treating osteoporosis.

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

-

Page/Page column 113-114, (2010/07/10)

The present invention relates to the identification of compounds and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the provided compounds.

Synthesis and Antiulcer Activity of 5,11-Dihydrobenzoxepinopyridines

Kumazawa, Toshiaki,Harakawa, Hiroyuki,Obase, Hiroyuki,Oiji, Yoshimasa,Tanaka, Hiroshi,et al.

, p. 779 - 785 (2007/10/02)

A series of substituted 5,11-dihydrobenzoxepinopyridines was synthesized and evaluated for antiulcer activity in water immersion/restrained stress ulcer assay in rats.Structure-activity relationships are described.Most of the tested compounds exhibited low affinity to the muscarinic acetylcholine receptor.The molecular features for the best activities are the 2-(diethylamino)ethylenediamine group at the 5-position of the oxepin ring and an oxepin skeleton rather than a thiepin or a pyran skeleton.Methyl and chlorine substitution on the benzene ring reduced the activity.Compound 11, 5-amino>-5,11-dihydrobenzoxepinopyridine trihydrochloride was selected for further evaluation.Synthesis and antiulcer activity of optically active 11 is described.There were no statistically significant differences between (+)-, (-), and (+/-)-11.Compound 11 showed weak antisecretory activity in pylorus-ligated rats.It is now under clinical evaluation as KW 5805.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 97900-77-1